Medpace is compounding fast with founder-led focus, strong Q2 results, and smart buybacks. The Optimist Fund sees long-term ...
The results of a clinical trial published last month targeted breast cancer "sleeper cells," which are cells that break away ...
MELBOURNE, Australia and INDIANAPOLIS, Oct. 23, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces that it has dosed the first patient in a Phase 1 ...
CBS News - Video on MSN
Scientists seek to wipe out breast cancer's "sleeper cells"
The results of a clinical trial published last month targeted breast cancer "sleeper cells," which are cells that break away ...
SHELTON, CONNECTICUT / ACCESS Newswire / October 15, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the “Company”), reports ...
MetroConnects, a sewer subdistrict in Greenville County that is a wastewater collection provider, announced that its rates ...
MetroConnects, a sewer subdistrict in Greenville County that is a wastewater collection provider, announced that its rates ...
Parikh is backed up by experienced CRO leader William Gannon Jr., M.D., who is LyfeSci’s chief medical officer. Gannon has ...
FX-909, a first-in-class investigational oral small molecule inhibitor of peroxisome proliferator-activated receptor gamma ...
Findings from a randomized and blinded clinical trial investigating repeated ketamine infusions for treating depression have ...
The termination of thousands of federal grants that fund clinical trials threatens to reverse substantial progress in ...
WEDNESDAY, Oct. 22, 2025 (HealthDay News) — A powerful new drug combo has yielded a major breakthrough for men battling an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback